Suchergebnisse - "Alessandra Vergori"

PubPharm (25)

1

Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort studyResearch in context

in: EClinicalMedicine | 2024

von Valentina Mazzotta | Alessandro Cozzi Lepri | Giulia Matusali | +85

2

Pharyngo-tonsillar involvement of Mpox in a cohort of men who have sex with men (MSM): A serious risk of missing diagnosis

in: Journal of Infection and Public Health | 2024

von Carmela Pinnetti | Annalisa Mondi | Valentina Mazzotta | +20

3

Risk Awareness as a Key Determinant of Early Vaccine Uptake in the Mpox Vaccination Campaign in an Italian Region: A Cross-Sectional Analysis

in: Vaccines | 2023

von Giulia Del Duca | Alessandro Tavelli | Ilaria Mastrorosa | +29

4

Treatment-Emergent Cilgavimab Resistance Was Uncommon in Vaccinated Omicron BA.4/5 Outpatients

in: Biomolecules | 2023

von Cesare Ernesto Maria Gruber | Fabio Giovanni Tucci | Martina Rueca | +15

5

HIV and Co-Infections: Updates and Insights

in: Viruses | 2023

von Francesco Di Gennaro | Alessandra Vergori | Davide Fiore Bavaro

6

Risk of COVID-19 in-hospital mortality in people living with HIV compared to general population according to age and CD4 strata: data from the ICONA network

in: International Journal of Infectious Diseases | 2023

von Andrea Giacomelli | Roberta Gagliardini | Alessandro Tavelli | +17

7

Long Term Assessment of Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in Persons Living with HIV

in: Vaccines | 2023

von Alessandra Vergori | Alessandro Cozzi-Lepri | Giulia Matusali | +19

8

Characteristics and Outcomes of COVID-19-Related Hospitalization among PLWH

in: Journal of Clinical Medicine | 2022

von Roberta Gagliardini | Alessandra Vergori | Patrizia Lorenzini | +21

9

Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial results

in: npj Vaccines | 2022

von Chiara Agrati | Concetta Castilletti | Simone Battella | +35

10

Emulation of a Target Trial From Observational Data to Compare Effectiveness of Casirivimab/Imdevimab and Bamlanivimab/Etesevimab for Early Treatment of Non-Hospitalized Patients With COVID-19

in: Frontiers in Immunology | 2022

von Valentina Mazzotta | Alessandro Cozzi-Lepri | Francesca Colavita | +18